统、互联网和部件及功能实现并和其 一起利用。
[0227] 图12示出可使用网络、或网络或计算机的部分实现本发明的一个或多个实施例 的系统。但本发明葡萄糖装置可在无网络的情况下操作。
[0228] 图12概略地示出可在其中实现本发明实例的示例性系统。在一个实施例中，葡萄 糖监测器可由本地在家或其他所需位置的受检者（或患者）实现。然而，在另选的实施例 中，葡萄糖监测器可在诊所环境或辅助环境中实现。例如，参考图12,诊所机构158提供用 于医生（例如164)或临床医生/助手诊断患有与葡萄糖相关的疾病和相关疾病与病症的 患者（例如159)的地方。葡萄糖监测装置10可用于监测和/或测试患者的葡萄糖水平一 作为独立式装置。应理解，尽管图中仅示出葡萄糖监测器装置10,但本发明的系统和其任 何部件可以图12中描绘的方式使用。该系统或部件可按需要或按要求附连到患者，或与患 者通信。例如，该系统或其部件的组合一包括葡萄糖监测器装置10 (或其他相关装置或系 统，诸如控制器，和/或胰岛素栗，或任何其他所需要或要求的装置或部件）一可通过带材 或管材（或其他医疗器械或部件）接触、通信或附连到患者，或可通过有线或无线连接进行 通信。此类监测和/或测试可以是短期的（例如临床访视）或长期的（例如临床住院或在 家）。葡萄糖监测装置输出可由医生（临床医生或助手）使用而采取适当动作，诸如对患者 进行胰岛素注射或喂食，或其他适当动作或建模。另选地，葡萄糖监测装置输出可传送到计 算机终端168,用于即时或未来分析。该传送可通过缆线或无线或任何其他合适的介质进 行。来自患者的葡萄糖监测装置输出还可传送到便携式装置，诸如PDA 166。具有改善的准 确度的葡萄糖监测装置输出可传送到葡萄糖监测中心172,用于处理和/或分析。此类传送 可以通过许多方式完成，诸如网络连接170,该网络连接可以是有线的或无线的。
[0229] 除葡萄糖监测装置输出之外，误差、用于准确度改善的参数和任何准确度相关信 息都可传送到例如计算机168和/或葡萄糖监测中心172,用于执行误差分析。这样可为葡 萄糖中心提供集中化的准确度监测、建模和/或准确度增强，这归因于葡萄糖传感器的重 要性。
[0230] 本发明的实例还可在与目标葡萄糖监测装置相关联的独立式计算装置中实现。图 IOA中示意性地示出可在其中实现本发明的实例的一种示例性计算装置（或其部分）。
[0231] 参考f献
[0232] 如以下所列举并贯穿本文档的以下专利、申请和出版物据此全文以引用方式并 入，并且不因为它们包括在本节中而认为是关于本发明的现有技术。
[0233] I. Rahbar S，Blumenfeld 0, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun. 1969 ；36:838-43.
[0234] 2.The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 ;329:977-86.
[0235] 3. UK Prospective Diabetes Study (UKPDS)Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes(UKPDS 33). The Lancet. 1998 ;352:837-53.
[0236] 4. Manley, Susan. Haemoglobin Ale-A marker for complications of type2 diabetes:The experience from the UK Prospective Diabetes Study(UKPDS), Clinical Chemistry and Laboratory Medicine 200341:9(1182-1190).
[0237] 5.Rohlfing CL,Wiedmeyer H，Little RR，England JD American Diabetes Association:Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010 ;33(Suppl. I) :S62-S69.
[0238] 6. ADA Standards of Care 2011 ；Diabetes Care, Volume 34, SupplementI，January 2011，S11-S6L
[0239] 7. Nathan, D M. , Kuenenj Jj Borg, Rj Zheng, Hj Schoenfeldj Dj Heine, R J. , Lor The Ale-Derived Average Glucose (ADAG) Study Group. Translating the AlC Assay Into Estimated Average Glucose Values Diabetes Care 31:1473-1478,2008.
[0240] 8. Makrisj Konstantinos ；Spanou, L. ；Rambaouni-Antoneli, A.； Koniari，Katerina ;Drakopoulos，Ioannis ;Rizos，Demetrios A. ；Haliassos, Alexander. Relationship between mean blood glucose and glycated hemoglobin in Type 2 diabetic patients Diabetic Medicine 200825:2(174-178).
[0241] 9. Temschj Wilhelm； Lugerj Anton F. ；Riedl,Michaela. HbAlc values calculated from blood glucose levels using truncated Fourier series and implementation in standard SQL database language. Methods of Information in Medicine 200847:4(346-355).
[0242] 10. Polneauj S. V. ；Lasserre,V. ；Fonfrede, M. ；Delattre, J. ；Benazeth, S. A different approach to analyzing age-related HbAlc values in non-diabetic subjects. Clinical Chemistry and Laboratory Medicine 200442:4 (423-428).
[0243] 11. Nowickaj Paulina ；Santoro, Nicola ；Liu, Haibei ；Lartaud, Derek ； Shaw, Melissa M. ；Goldberg, Rachel ；Guandalini, Cindy ；Savoye, Mary ；Rose, Paulina ； Caprioj Sonia. Utility of hemoglobin Ale for diagnosing prediabetes and diabetes in obese Children and adolescents. Diabetes Care 201134:6 (1306-1311).
[0244] 12. Hamren，Bengt ;Bjork，E. ;Sunzel，M. ;Karlsson，Mats 0· Models for plasma glucose, HbAlcj and hemoglobin interrelationships in patients with type 2diabetes following tesaglitazar treatment. Clinical Pharmacology and Therapeutics 200884:2 (228-235).
[0245] 13. Heislerj Michele M. ；Piette, John D. ；Spencer, Michael S. ；Kieffer, Edie ； Vijanj Sandeep.The relationship between knowledge of recent HbAlc values and diabetes care understanding and self-management.Diabetes Care 200528:4(816-822).
[0246] 14. Landgrafj Rudiger. The relationship of postprandial glucose to HbAlc. Diabetes Metab Res Rev 200420:SUPPL 2(S9-S12).
[0247] 15. Yamamoto-Hondaj Ritsuko ；Kitazato, Hiroji ；Hashimoto, Shinij ； TakahashijYoshihiko ；YoshidajYoko ；Hasegawa, Chiyoko ；Akanuma,Yasuo ； Noda，Mitsuhiko. Distribution of blood glucose and the correlation between blood glucose and hemoglobin Ale levels in diabetic outpatients. Endocrine Journal 200855:5(913-923).
[0248] 16. Goldstein DE，Little RR，Lorenz RA等人，Tests of glycemia in diabetes. Diabetes Care. 2004 ；27:1761-73.
[0249] 17.Trevino, G. On Ale and its dependence on PG level. Diabetes Research and Clinical Practice 200673:1(111-112).
[0250] 18. Trevino,G.On the weighted-average relationship between plasma glucose and HbAlc. Diabetes Care 200618:2(466-467).
[0251] 19. Trevino, G. A nonlinear relation between glucose and Ale. Diabetes Research and Clinical Practice 200879:3 (el4).
[0252] 20. Zielkej Roland ；Henrichs, H. R. Use of the HbAlc determination as long-term parameter in diabetes control. Klinisches Labor 199339:12 (988-990).
[0253] 21. Ollertonj R. L. ；Luzio, S. D. ；0wens, D. R. Contribution of fasting and postprandial plasma glucose to HbA(Ic)Diabetic Medicine 200522:7 (954-955.
[0254] 22. Osterman-Golkarj S. M. ；Vesper, H. ff. Assessment of the relationship between glucose and Ale using kinetic modelling. Journal of Diabetes and its Complications 200620:5 (285-294).
[0255] 23.Kahromj M. An innovative mathematical model: A key to the riddle of HbAlc. International Journal of Endocrinology 2010Article Number481326.
[0256] 24. Kovatchevj B. P. ；Cox, D. J. ；Straume, M. ；Farhy, L. S. Association of selfmonitoring blood glucose profiles with glycolysated hemoglobin in patients with insulin-dependent diabetes. Methods in Enzymology 2000321 (410-417)
[0257] 25. Kovatchev BPjStraume MjCox DJjFarhy LS. Risk analysis of blood glucose data:A quantitative approach to optimizing the control of insulin dependent diabetes. J of Theoretical Medicine, 3:1-10, 2001.
[0258] 26. Kovatchev BPj Cox DJ. Numerical Estimation of HbAic from Routine Self-Monitoring Data in People With Type land Type 2Diabetes Mellitus(2004). In:Methods in Enzymology，384:Numerical Computer Methods. Part E:94-106. M Johnson 和 L Brand 编辑，Academic Press，NY. ISBN: 978-0-12-182789-2.
[0259] 27. Kovatchev BPj Cox DJj Kumar A, Gonder-Frederick LA, Clarke WL (2003). Algorithmic Evaluation of Metabolic Control and Risk of Severe Hypoglycemia in Type land Type 2Diabetes Using Self-Monitoring Blood Glucose (SMBG) Data. Diabetes Technology and Therapeutics. 5(5):817-828.
[0260] 28. Kovatchev BPjOtto EjCox DjGonder-Frederick LjClarke ff. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006年 11 月；29(11) :2433-8.
[0261] 29. Kovatchev BPjMendosa PjAnderson SjHawley JSjRitterband LMj Gonder-Frederick L.Effect of automated bio-behavioral feedback on the control of type ldiabetes. Diabetes Care.2011 年 2 月；34(2):302-7. Epub 2011 年 I 月7日。
[0262] 30. Clarke WLj Cox Dj Gonder-Frederick LA, Carter Wj Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987 ; 10 (5) :622-8.
[0263] 31. Parkes JL，Slatin SL，Pardo Sj Ginsberg BH. A new consensus error grid to evaluate the clinical signifcance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000 ；23 (8):1143-8.
[0264] 32. Kovatchev BPjGonder-Frederick LAjCox DJjClarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors:continuous gluc